Patients Eagerly Awaited a Generic Drug. Then They Saw the Price. by KATIE THOMAS

By KATIE THOMAS

Teva Pharmaceuticals announced it would sell a “lower-cost” alternative to Syprine, an old drug that costs more than $21,000. But the new generic version costs nearly as much.

Published: February 22, 2018 at 07:00PM

from NYT Health http://ift.tt/2sOiwTA
via IFTTT

from WordPress http://ift.tt/2EOxgne
via IFTTT